Trials / Withdrawn
WithdrawnNCT02477657
Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Malignant ascites leads to significant morbidity in patients with terminal cancer. Paracentesis can provide relief, but repeat hospital visits, pain, and short duration of relief after paracentesis are detrimental to quality of life(QOL). Two devices are available as alternatives to paracentesis. The impact of either device on QOL has not fully been explored. A pilot nonrandomized trial measuring palliative care QOL and ascites symptom relief using validated survey instruments is proposed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Paracentesis | Paracentesis |
| DEVICE | Tunneled Intraperitoneal Drain (IPD) | Tunneled Intraperitoneal Drain (IPD) |
| DEVICE | Peritoneal-Venous shunts (PVS) | Peritoneal-Venous shunts (PVS) |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2022-07-01
- Completion
- 2023-07-01
- First posted
- 2015-06-23
- Last updated
- 2022-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02477657. Inclusion in this directory is not an endorsement.